Cite
HARVARD Citation
Laquente, B. et al. (n.d.). 2250 Phase II trial of neoadjuvant gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy in resectable pancreatic adenocarcinoma. A GEMCAD 10–03 trial. European journal of cancer. pp. S416-. [Online].